Maggie is an editor for The American Journal of Managed Care® (AJMC®) and produces written, video, and podcast content covering several disease states. She joined AJMC® in 2019, and has been with AJMC®’s parent company, MJH Life Sciences®, since 2014, when she started as a copy editor.
She has a BA in English from Penn State University. You can connect with Maggie on LinkedIn.
Heart Failure Prognosis Not Improved by Risk Score PredictionAugust 10th 2022
The REVEAL-HF study investigated using risk scores to improve patient outcomes through targeted interventions, including treatment initiation and intensity, end-of-life care, and hospitalization and mortality risks.
NGF-Based MRD Assessment Demonstrates Potential to Predict MM Disease ProgressionAugust 4th 2022
Previous studies have produced heterogeneous results on next-generation flow (NGF)-based minimal residual disease (MRD) detection, despite improvements to the method’s reproducibility and sensitivity, prompting the present authors to investigate its clinical utility.
Risk of Keratinocyte Carcinoma Increases With Pediatric Solid Organ TransplantAugust 2nd 2022
This new study investigated keratinocyte carcinoma mortality and morbidity rates following pediatric solid organ transplant. Little is known on these associations in pediatric patients; more is known of these outcomes among adult patients.
Dr Anchalee Avihingsanon: ALLIANCE Trial Findings Are Meaningful for HIV/HBV CoinfectionJuly 29th 2022
The ALLIANCE trial is the first randomized blinded trial to investigate tenofovir alafenamide vs tenofovir disoproxil fumarate in treatment-naive individuals who have comorbid HIV/hepatitis B virus (HBV) infection.
Knowledge of Health Insurance, Financial Literacy Fail to Prevent Financial Hardship Among Patients With CancerJuly 27th 2022
A team of investigators from across the United States investigated a potential connection between patients’ health insurance literacy and their reported financial hardship.
Reflectance Confocal Microscopy Improves Skin Cancer Diagnosis in New TrialJuly 25th 2022
This prospective study on reflectance confocal microscopy, a high-resolution and noninvasive form of imaging for skin cancer, investigated if the diagnostic method could improve accuracy results by 30% following dermoscopy.
ASCO Spotlight With Hope S. Rugo, MD, FASCO, on Clinical Trial Minority Recruitment, PALOMA-2 FindingsJuly 21st 2022
Hope S. Rugo, MD, FASCO, professor of medicine and director, Breast Oncology and Clinical Trials Education, University of California, San Francisco, Helen Diller Family Comprehensive Cancer Center, said PALOMA-2 results don’t match what she has seen in practice.
Dr Anne McCall Discusses How Louisiana’s History Will Shape Xavier/Takeda PartnershipJuly 21st 2022
In part 2 of our interview with Anne McCall, PhD, provost and senior vice president for academic affairs at Xavier University of Louisiana, she discusses in greater detail the university’s 3-year partnership with Takeda, in particular how the directions it goes in will be influenced by the history of unequal health care delivery in the state.
ASCO Spotlight With Kim A. Reiss, MD, on CAR Macrophages and Other Developments in Pancreatic CancerJuly 21st 2022
Kim A. Reiss, MD, assistant program director, assistant professor of medicine, Hospital of the University of Pennsylvania, Philadelphia, discusses 2 abstracts presented during ASCO.
ASCO Spotlight With Randall A. Oyer, MD: Clinical Trials Must Be Accessible to EveryoneJuly 21st 2022
Randall A. Oyer, MD, medical director of the Ann B. Barshinger Cancer Institute, medical director of oncology, and medical director of the Cancer Risk Evaluation Program, Lancaster General Health, discusses recommendations to improve diversity in clinical trials.